| Literature DB >> 35297271 |
Anitha S John, Jamie L Jackson, Philip Moons, Karen Uzark, Andrew S Mackie, Susan Timmins, Keila N Lopez, Adrienne H Kovacs, Michelle Gurvitz.
Abstract
It is now expected that most individuals with congenital heart disease will survive to adulthood, including those with complex heart conditions. Maintaining lifelong medical care requires those with congenital heart disease to eventually transfer from pediatric to adult-oriented health care systems. Developing health care transition skills and gaining independence in managing one's own health care is imperative to this process and to ongoing medical and psychosocial success. This scientific statement reviews the recent evidence regarding transition and provides resources, components, and suggestions for development of congenital heart disease transition programs with the goals of improving patient knowledge, self-management, and self-efficacy skills to the level they are capable to eventually integrate smoothly into adult-oriented health care. Specifically, the scientific statement updates 3 sections relevant to transition programming. First, there is a review of specific factors to consider, including social determinants of health, psychosocial well-being, and neurocognitive status. The second section reviews costs of inadequate transition including the public health burden and the impairment in individual quality of life. Finally, the last section discusses considerations and suggestions for transition program design including communication platforms, a family-centered approach, and individual models. Although this scientific statement reviews recent literature surrounding transitions of care for individuals with congenital heart disease there remain significant knowledge gaps. As a field, we have yet to determine ideal timing and methods of transition, and barriers to transition and transfer remain, particularly for the underserved populations. The consequences of poor health care transition are great and garnering outcomes and information through organized, multifaceted, collaborative approaches to transition is critical to improving the lifelong care of individuals with congenital heart disease.Entities:
Keywords: AHA Scientific Statements; adolescent; heart defects, congenital; self‐management; social determinants of health; transition to adult care
Mesh:
Year: 2022 PMID: 35297271 PMCID: PMC9075425 DOI: 10.1161/JAHA.122.025278
Source DB: PubMed Journal: J Am Heart Assoc ISSN: 2047-9980 Impact factor: 6.106
Figure 1The impact of social determinants of health on health care transition. ACHD indicates adults with congenital heart disease; and CHD, congential heart disease.
Key Principles and Guidelines for a congenital Heart Disease–Specific Health Care Transition Program
| 1. Emphasize patient self‐management, self‐advocacy, and engagement, and educate caregivers to encourage patients to move into a primary ownership role with some shared decision making |
| 2. Guide patients in building their medical knowledge and care coordination skills and facilitate caregivers moving into a more supportive role, emphasizing the rationale for transition while acknowledging their fears and concerns |
| 3. Acknowledge individual congenital heart disease subtypes along with the cardiac, noncardiac, and lifestyle (exercise) complexities associated with each congenital heart disease subtype |
| 4. Understand the patient diversity in neurocognitive development, intellectual disabilities, mental health conditions, and comorbidities to provide patient and family psychosocial and educational support from medical care team |
| 5. Emphasize lifelong care, including identifying or knowing how to identify, an adult congenital heart disease specialist before transfer of care |
| 6. Advocate for health equity in transition by recognizing the role of health literacy and social determinants of health for all families in navigating a complex medical system, particularly those with lower socioeconomic status |
| 7. Educate members of pediatric and adult congenital heart disease teams to address the transition needs and provide transition education and skills to all patients with congenital heart disease, particularly those who also have neurodevelopmental deficits |
Key Transition Curriculum Components for Adolescents With Congenital Heart Disease
| Topic | Subtopic |
|---|---|
| Introduction to transition | What is “transition”? How does it differ from “transfer”? |
| Setting timeline expectations for transition and transfer | |
| Changing patient role (taking charge) and caregiver role (supportive) | |
| Need for lifelong care | |
| The medical home—what this means, and the importance of having a primary care physician | |
| How to find a family physician or general internist and an adult congenital heart disease physician | |
| Differences between adult versus child‐oriented health care settings—“what to expect on the other side” | |
| Confidentiality, medical record access | |
| Medical knowledge | Discussion of normal heart anatomy—with diagram |
| Review of patient’s heart anatomy at birth—with diagram | |
| Review of catheter and surgical interventions | |
| Review of current/residual/future hemodynamic challenges | |
| Anticipated future catheter or surgical interventions, if applicable | |
| Late potential cardiac complication and noncardiac morbidities | |
| Explanation of arrhythmias, if applicable | |
| Review of pacemaker/AICD programming, if applicable | |
| Review of current medications, if applicable—name, dose, and rationale | |
|
3‐Sentence summary of cardiac/medical condition:
My age, diagnosis, and brief medical history (eg, “I am 16, was born with tetralogy of Fallot, and had heart surgery as a baby”) My treatment plan (eg, “My pumping chambers are being monitored, and I might need a valve replacement”) My concern/question to talk about during this visit (“eg, I’m having a harder time walking up stairs than in the past”) | |
| Urgency versus emergency—Symptoms that warrant medical attention | |
| Create and review portable health summary/passport | |
| Endocarditis and potential need for antibiotic prophylaxis | |
| Living with congenital heart disease | Potential challenges in scholastic achievement (learning disabilities and ADHD), if applicable |
| Educational/vocational interests, and implications for congenital heart disease, if applicable | |
| Importance of physical activity and appropriate levels for all congenital heart disease types | |
| Sports restrictions, if applicable | |
| Birth control, pregnancy, and congenital heart disease risk in offspring (males and females) | |
| Diet and weight management | |
| Smoking, vaping, alcohol, and drugs | |
| Anxiety and depression | |
| Connecting with others—how and where to find others living with congenital heart disease | |
| Sibling/friend/parent/partner support | |
| Insurance planning and avoiding lapses in medical care | |
| Advanced care directives/medical power of attorney | |
| Approach to requiring noncardiac surgery | |
| Self‐management | What is “self‐management” and why does it matter? |
|
Examples of self‐management skills relevant to chronic disease management:
Making appointments Taking medications independent of parent/guardian Refilling prescriptions Attending part of appointments alone Calling the doctor about concerning changes in health | |
| Self‐advocacy | What is “self‐advocacy” and why does it matter? |
|
Examples of self‐advocacy skills relevant to chronic disease management:
Keeping a calendar of appointments Preparing questions before the appointment Making sure the questions are answered Answering questions of the doctor or nurse Making use of community support services as needed |
ADHD indicates attention‐deficit/hyperactivity disorder; and AICD, automatic implantable cardioverter‐defibrillator.
Sample Transition Curriculum Tasks for Adolescents With Congenital Heart Disease
| Action | Date started | Date completed | Care coordination | Medical knowledge |
|---|---|---|---|---|
| Suggested timeframe: Early transition | ||||
| Set expectations with parent and child regarding transition | ||||
| Sees doctor independently for part of visit; prepares 1 question for each medical appointment | ||||
| Knows how to access health care professional contact information | ||||
| Learns the name of their cardiac diagnosis | ||||
| Learns names and roles of team members | ||||
| Learns the names of their medications | ||||
| Suggested timeframe: Middle transition | ||||
| Patient is primary source of communication with the doctor during their appointment | ||||
| Practices making their own medical appointments | ||||
| Learns about their insurance and sets up an insurance contingency if they are at risk for losing insurance once turn 18 y | ||||
| Learns about how to fill a prescription | ||||
| Can provide a 3‐sentence summary of their cardiac history | ||||
| Takes medications independently | ||||
| Can explain what their medications are for and knows the doses | ||||
| Understands medical urgencies and emergencies to be concerned about | ||||
| Transition team creates or updates a portable medical summary with youth | ||||
| Learns about their insurance options | ||||
| Suggested timeframe: Late transition | ||||
| Patient sees the doctor independently for majority of or entire appointment | ||||
| Makes their own medical appointment and coordinates upcoming procedures | ||||
| Introduced to an adult congenital heart disease health care professional or learns how to find an adult congenital heart disease professional and Center | ||||
| Learns about advanced directives, living wills, and medical power of attorney | ||||
| Can explain cardiac diagnosis to another person | ||||
| Understands critical need for lifelong care and healthy lifestyle | ||||
| Updates their portable medical summary as needed (eg, after medical appointments) | ||||
Suggested age ranges can vary based on neurocognitive status and other patient factors.
| Writing group member | Employment | Research grant | Other research support | Speakers’ bureau/honoraria | Expert witness | Ownership interest | Consultant/advisory board | Other |
|---|---|---|---|---|---|---|---|---|
| Anitha S. John | Children’s National Medical Center | None | None | None | None | None | None | None |
| Michelle Gurvitz | Boston Children’s Hospital | PCHA | None | None | None | None | None | None |
| Jamie L. Jackson | Nationwide Children's Hospital | None | None | None | None | None | None | None |
| Adrienne H. Kovacs | Oregon Health & Science University | Canadian Institutes of Health Research | None | None | None | None | None | None |
| Keila N. Lopez | Baylor College of Medicine | NIH (PI on an NIH K23) | None | None | None | Polyvascular | None | None |
| Andrew S. Mackie | Stollery Children's Hospital (Canada) | None | None | None | None | None | None | None |
| Philip Moons | University of Leuven (Belgium) | None | None | None | None | None | None | None |
| Susan Timmins | Beach Bistro | None | None | None | None | None | None | None |
| Karen Uzark | University of Michigan | None | None | None | None | None | None | None |
This table represents the relationships of writing group members that may be perceived as actual or reasonably perceived conflicts of interest as reported on the Disclosure Questionnaire, which all members of the writing group are required to complete and submit. A relationship is considered to be “significant” if (a) the person receives $10 000 or more during any 12‐month period, or 5% or more of the person’s gross income; or (b) the person owns 5% or more of the voting stock or share of the entity, or owns $10 000 or more of the fair market value of the entity. A relationship is considered to be “modest” if it is less than “significant” under the preceding definition.
Modest.
Significant.
| Reviewer | Employment | Research grant | Other research support | Speakers’ bureau/honoraria | Expert witness | Ownership interest | Consultant/advisory board | Other |
|---|---|---|---|---|---|---|---|---|
| Chinmay M. Trivedi | University of Massachusetts Medical School | None | None | None | None | None | None | None |
| James S. Tweddell | Cincinnati Children's Hospital Medical Center | None | None | None | None | None | None | None |
| Kevin J. Whitehead | University of Utah | None | None | None | None | None | None | None |
This table represents the relationships of reviewers that may be perceived as actual or reasonably perceived conflicts of interest as reported on the Disclosure Questionnaire, which all reviewers are required to complete and submit. A relationship is considered to be “significant” if (a) the person receives $10 000 or more during any 12‐month period, or 5% or more of the person’s gross income; or (b) the person owns 5% or more of the voting stock or share of the entity, or owns $10 000 or more of the fair market value of the entity. A relationship is considered to be “modest” if it is less than “significant” under the preceding definition.